Show simple item record

dc.contributor.authorHajilooi, M
dc.contributor.authorAbasi, M
dc.contributor.authorBazmani, A
dc.contributor.authorAhmadi, A
dc.contributor.authorMatini, M
dc.contributor.authorSolgi, G
dc.contributor.authorSardarian, K
dc.date.accessioned2018-08-26T08:54:34Z
dc.date.available2018-08-26T08:54:34Z
dc.date.issued2015
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54160
dc.description.abstractBackground: Interleukin (IL)-8 plays important roles in the recruitment and activation of immune cells during visceral leishmaniasis (VL). Genetic variations in IL-8 modulate the expression of IL-8 protein and may be associated with VL. This study aimed to evaluate polymorphisms at the IL-8 ?251 position in VL patients. Methods: This cross-sectional study was performed on three groups: Leishmania-seropositive patients with clinical symptoms of VL (n=91), seropositive patients without clinical symptoms (n=104), and healthy controls (n=110). Polymorphisms at the IL-8?251 position were analyzed using allele-specific polymerase chain reaction (PCR). Anti-Leishmania antibody titers were assessed by immunofluorescence. Results: IL-8?251 polymorphism was significantly associated with VL (P<0.002). The IL-8?251 T/T genotype was significantly higher in group 1 than in groups 2 and 3 (P<0.002). The validity of the data was analyzed using Hardy-Weinberg equilibrium and one-way analysis of variance (ANOVA), as well as x2 tests. Conclusions: IL-8?251 polymorphism was significantly associated with impaired immune re-sponses in VL and might be considered a risk factor for disease development. é 2015 Health Hamadan University of Medical Sciences. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofJournal of Research in Health Sciences
dc.subjectadenine
dc.subjectinterleukin 8
dc.subjectLeishmania antibody
dc.subjectparasite antibody
dc.subjectthymine
dc.subjectunclassified drug
dc.subjectIL8 protein, human
dc.subjectinterleukin 8
dc.subjectallele
dc.subjectantibody titer
dc.subjectArticle
dc.subjectclinical feature
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectDNA polymorphism
dc.subjectgenetic association
dc.subjectgenetic screening
dc.subjectgenotype
dc.subjecthuman
dc.subjectimmunofluorescence test
dc.subjectmajor clinical study
dc.subjectpolymerase chain reaction
dc.subjectsymptom
dc.subjectvalidation process
dc.subjectvisceral leishmaniasis
dc.subjectgene frequency
dc.subjectgenetic predisposition
dc.subjectgenetics
dc.subjectgenotype
dc.subjectimmunity
dc.subjectimmunology
dc.subjectLeishmania
dc.subjectmetabolism
dc.subjectparasitology
dc.subjectsingle nucleotide polymorphism
dc.subjectvisceral leishmaniasis
dc.subjectAlleles
dc.subjectCross-Sectional Studies
dc.subjectGene Frequency
dc.subjectGenetic Association Studies
dc.subjectGenetic Predisposition to Disease
dc.subjectGenotype
dc.subjectHumans
dc.subjectImmunity
dc.subjectInterleukin-8
dc.subjectLeishmania
dc.subjectLeishmaniasis, Visceral
dc.subjectPolymorphism, Single Nucleotide
dc.titleEvaluation of interleukin-8 ?251 T/A polymorphisms in visceral leishmaniasis
dc.typeArticle
dc.citation.volume15
dc.citation.indexScopus


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record